Skip to main content

Table 1 Patient and treatment characteristics with comparison between EFI and TNI and between stages I/II and stage III disease

From: Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation

 

All

EFI

TNI

p-value

Stage I/II

Stage III

p-value

# patients

107

 

48

 

59

  

86

21

 

Age

      

<0.001

    

<0.001

 median/range [years]

57

26 - 83

66

37 - 83

51

26 - 74

 

61

27 – 83

51

26 - 68

 

 ≥60 years

48

45%

35

73%

13

22%

 

45

52%

3

14%

 

Sex [male]

59

57%

26

55%

33

56%

NS

49

57%

10

48%

 

Karnofsky Performance status

      

<0.001

    

NS

median/range

90

50 - 100

90

50 - 100

100

80 - 100

 

90

50 – 100

90

70 – 100

 

B-Symptoms

1

1%

0

0%

1

2%

NS

0

0%

1

5%

NS

LDH

      

NS

    

0.03

 Elevated

16

15%

9

19%

7

12%

 

8

9%

8

38%

 

 Normal

63

59%

29

60%

34

58%

 

55

64%

8

24%

 

 unknown

28

26%

10

21%

18

30%

 

23

27%

5

38%

 

Ann Arbor stage

      

0.04

     

 I

50

47%

27

56%

23

39.0%

      

 II

36

34%

18

38%

18

30.5%

      

 III

21

20%

3

6%

18

30.5%

      

Bulk ≥7.5 cm

5

5%

2

4%

3

5%

NS

3

3%

2

9%

NS

Radiotherapy dose median/range [Gy]

38

25 - 50

38

27 - 50

37

25 - 46

NS

37

25 - 50

37

29 - 46

NS